StockData
Sigyn Therapeutics, Inc. logo

Sigyn Therapeutics, Inc. (SIGY) bonds

SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2025, quý kết thúc ngày Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 0/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $48.16KP/E –Yield –

Debt

Borrowings on the balance sheet, Sep 30, 2025

Total debt
$3.09M
$1.03M due within a year
Net debt
$3.00M
After $85.57K of cash
Implied interest rate
–
FY2024 interest ÷ average debt
Interest coverage
–
FY2024 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2024

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Sigyn Therapeutics's 10-Q for the period ended Sep 30, 2025

IssueMaturesAmount issuedCarrying value
Two Thousand Twenty Five Convertible Two Notes
Convertible
Dec 31, 2027$232.10K–
Two Thousand Twenty Four Convertible Notes Four
Convertible at $2 a share
Dec 31, 2027$171.30K–
Two Thousand Twenty Two Convertible Notes Two
Convertible at $2 a share
Dec 31, 2027$770.00K–
Convertible Promissory Note Five
Convertible
––$418.62K
Convertible Promissory Note Four
Convertible
––$234.70K
Convertible Promissory Note One
Convertible
––$834.77K
Convertible Promissory Note Three
Convertible
––$403.73K
Convertible Promissory Note Two
Convertible
––$1.28M
Osher And Brio Notes Converted In Fiscal Two Thousand And Twenty Four––$841.42K
Regulation D––$379.72K
Two Thousand Twenty Five Convertible Notes Five
Convertible at $2 a share
–$178.20K–

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?